Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 4, 2011, Pages 678-685

  Adam, Oliver ^a   Theobald, Katharina ^a   Lavall, Daniel ^a   Grube, Markus ^b   Kroemer, Heyo K ^b   Ameling, Sabine ^b   Schäfers, Hans Joachim ^a   Böhm, Michael ^a   Laufs, Ulrich ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Atrial fibrillation; CTGF; Fibrosis; Lysyl oxidase; Rac1

Indexed keywords

3 AMINOPROPIONITRILE; 4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; ANGIOTENSIN II; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; GUANOSINE TRIPHOSPHATASE; MESSENGER RNA; PROTEIN LYSINE 6 OXIDASE; RAC1 PROTEIN; SMALL INTERFERING RNA;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CROSS LINKING; FEMALE; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION; WESTERN BLOTTING;

AGED; ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; ATRIAL FIBRILLATION; BLOTTING, WESTERN; CELLS, CULTURED; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEART ATRIA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-LYSINE 6-OXIDASE; RAC1 GTP-BINDING PROTEIN; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS MUSCULUS;

EID: 79952071069     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.12.019     Document Type: Article

References (43)

1. Nattel S., Opie L.H. Controversies in atrial fibrillation. Lancet 2006, 367(9506):262-272.
2. Allessie M., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002, 54(2):230-246.
3. Li D., Fareh S., Leung T.K., Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort 1. Circulation 1999, 100(1):87-95.
4. Nattel S., Burstein B., Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 2008, 1(1):62-73.
5. Silver M.A., Pick R., Brilla C.G., Jalil J.E., Janicki J.S., Weber K.T. Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis. Cardiovasc Res 1990, 24(9):741-747.
6. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997, 96(4):1180-1184.
7. Boldt A., Wetzel U., Lauschke J., Weigl J., Gummert J., Hindricks G., et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 2004, 90(4):400-405.
8. Prockop D.J., Kivirikko K.I. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 1995, 64:403-434.
9. Reiser K., McCormick R.J., Rucker R.B. Enzymatic and nonenzymatic cross-linking of collagen and elastin. FASEB J 1992, 6(7):2439-2449.
10. Kagan H.M., Trackman P.C. Properties and function of lysyl oxidase. Am J Respir Cell Mol Biol 1991, 5(3):206-210.
11. Adam O., Frost G., Custodis F., Sussman M.A., Schäfers H.J., Böhm M., et al. Role of Rac1 GTPase activation in atrial fibrillation. J Am Coll Cardiol 2007, 50(4):359-367.
12. Adam O., Lavall D., Theobald K., Hohl M., Grube M., Ameling S., et al. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J Am Coll Cardiol 2010, 55(5):469-480.
13. Custodis F., Eberl M., Kilter H., Böhm M., Laufs U. Association of RhoGDI alpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy. Cardiovasc Res 2006, 71(2):342-351.
14. Sussman M.A., Welch S., Walker A., Klevitsky R., Hewett T.E., Price R.L., et al. Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1. J Clin Invest 2000, 105(7):875-886.
15. Reil J.C., Hohl M., Oberhofer M., Kazakov A., Kaestner L., Mueller P., et al. Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling. Cardiovasc Res 2010, 87(3):485-493.
16. Li Y.Y., Feng Y., McTiernan C.F., Pei W., Moravec C.S., Wang P., et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation 2001, 4; 104(10):1147-1152.
17. Lopez-De Leon A., Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985, 33(8):737-743.
18. Liao J.K., Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005, 45:89-118.
19. Laufs U., Kilter H., Konkol C., Wassmann S., Böhm M., Nickenig G. Impact of HMG CoA reductase inhibition on small GTPases in the heart. Cardiovasc Res 2002, 53(4):911-920.
20. Magnusson M.K., Mosher D.F. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol 1998, 18(9):1363-1370.
21. Pankov R., Yamada K.M. Fibronectin at a glance. J Cell Sci 2002, 115(Pt 20):3861-3863.
22. Sottile J., Hocking D.C. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 2002, 13(10):3546-3559.
23. Velling T., Risteli J., Wennerberg K., Mosher D.F., Johansson S. Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J Biol Chem 2002, 277(40):37377-37381.
24. Fogelgren B., Polgar N., Szauter K.M., Ujfaludi Z., Laczko R., Fong K.S., et al. Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J Biol Chem 2005, 280(26):24690-24697.
25. Xu J., Cui G., Esmailian F., Plunkett M., Marelli D., Ardehali A., et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004, 109(3):363-368.
26. Hornstra I.K., Birge S., Starcher B., Bailey A.J., Mecham R.P., Shapiro S.D. Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem 2003, 278(16):14387-14393.
27. Maki J.M., Rasanen J., Tikkanen H., Sormunen R., Makikallio K., Kivirikko K.I., et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 2002, 106(19):2503-2509.
28. Lopez B., Querejeta R., Gonzalez A., Beaumont J., Larman M., Diez J. Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure. Hypertension 2009, 53(2):236-242.
29. Smith-Mungo L.I., Kagan H.M. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol 1998, 16(7):387-398.
30. Sivakumar P., Gupta S., Sarkar S., Sen S. Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy. Mol Cell Biochem 2008, 307(1-2):159-167.
31. Lopez B., Gonzalez A., Hermida N., Valencia F., de Teresa E., Diez J. Role of lysyl oxidase in myocardial fibrosis. From basic science to clinical aspects. Am J Physiol Heart Circ Physiol 2010, 299(1):H1-H9.
32. Molnar J., Fong K.S., He Q.P., Hayashi K., Kim Y., Fong S.F., et al. Structural and functional diversity of lysyl oxidase and the LOX-like proteins. Biochim Biophys Acta 2003, 1647(1-2):220-224.
33. Li D., Shinagawa K., Pang L., Leung T.K., Cardin S., Wang Z., et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001, 104(21):2608-2614.
34. Kawano H., Do Y.S., Kawano Y., Starnes V., Barr M., Law R.E., et al. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts 39. Circulation 2000, 101(10):1130-1137.
35. Goette A., Arndt M., Rocken C., Spiess A., Staack T., Geller J.C., et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans 96. Circulation 2000, 101(23):2678-2681.
36. Saygili E., Rana O.R., Meyer C., Gemein C., Andrzejewski M.G., Ludwig A., et al. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol 2009, 104(4):435-448.
37. Ellinghaus P., Scheubel R.J., Dobrev D., Ravens U., Holtz J., Huetter J., et al. Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays. J Thorac Cardiovasc Surg 2005, 129(6):1383-1390.
38. Ruperez M., Lorenzo O., Blanco-Colio L.M., Esteban V., Egido J., Ruiz-Ortega M. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 2003, 108(12):1499-1505.
39. Takemoto M., Node K., Nakagami H., Liao Y., Grimm M., Takemoto Y., et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001, 108(10):1429-1437.
40. Burstein B., Qi X.Y., Yeh Y.H., Calderone A., Nattel S. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc Res 2007, 1; 76(3):442-452.
41. Lin C.S., Lai L.P., Lin J.L., Sun Y.L., Hsu C.W., Chen C.L., et al. Increased expression of extracellular matrix proteins in rapid atrial pacing-induced atrial fibrillation. Heart Rhythm 2007, 4(7):938-949.
42. Lendeckel U., Dobrev D., Goette A. Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation. Br J Pharmacol 2010, 159(8):1581-1583.
43. Dobrev D., Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet 2010, 375(9721):1212-1223.